OCA
CRDF icon

Octagon Capital Advisors’s Cardiff Oncology CRDF Stock Holding History

Octagon Capital Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-982,753
Closed -$5.91M – 26
2021
Q4 		$5.91M Hold
982,753
– – 1.15% 19
2021
Q3 		$6.54M Hold
982,753
– – 1.61% 18
2021
Q2 		$6.54M Buy
982,753
+332,753
+51% +$2.82M 1.35% 21
2021
Q1 		$6.02M Hold
650,000
– – 2.27% 18
2020
Q4 		$11.7M Buy
+650,000
New +$11.4M 4.05% 11

Other funds holding CRDF

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return